Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Chronic kidney disease	1
End Stage Renal Disease With Renal Transplant	1
End Stage Renal Disease on Dialysis	1
End-Stage Renal Disease	1
Kidney Failure	1
Kidney Ischemia	1
Kidney Transplant Rejection	1
Kidney Tumor	1

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
NCT07053462 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 85 Years · Sex: All (male and female) · 1 location

1 recruiting trial across 8 conditions.

No. For the full record, search ClinicalTrials.gov.